TACROLIMUS RESCUE THERAPY FOR CORTICOSTEROID-RESISTANT AND POLYCLONAL ANTIBODY-RESISTANT KIDNEY ALLOGRAFT REJECTIONS

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

NADERI GH.H.; MEHRABAN DARAB; GANJI M.R.; YAHYAZADEH S.R.; LATIF A.H.

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: UROLOGY JOURNAL Year:2009 | Volume:6 | Issue:1 Page(s): 31-34

Download Full-Text

View:

251

Download:

128

Cites:

Information Journal Paper

Title

TACROLIMUS RESCUE THERAPY FOR CORTICOSTEROID-RESISTANT AND POLYCLONAL ANTIBODY-RESISTANT KIDNEY ALLOGRAFT REJECTIONS

Author(s)

Keywords

KIDNEY TRANSPLANTATION

TACROLIMUS

GRAFT REJECTION

GRAFT SURVIVAL

Abstract

Introduction: The conventional treatment of acute kidney allograft rejection consists of high-dose corticosteroids and polyclonal antibodies. We report our experience of TACROLIMUS rescue therapy in patients with acute rejections refractory to corticosteroids and polyclonal antibodies.Materials and Methods: A total of 34 patients with a mean age of 42.3 years and clinical diagnosis of acute kidney allograft rejection underwent TACROLIMUS rescue therapy when treatment with corticosteroids and polyclonal antibodies failed. Kidney allograft biopsy results were available in 21 patients. All of the patients received TACROLIMUS, 0.1 mg twice daily, and in those who responded to the therapy after 4 to 6 months, TACROLIMUS was replaced with cyclosporine.Results: Pathologic examination of 21 biopsy specimens of the kidney allografts showed acute vascular rejection in 7 patients (33.3%), acute humoral rejection in 6 (28.6%), acute cellular rejection in 3 (14.3%), and accelerated acute rejection in 3 (14.3%). Twenty-six patients (76.5%) responded to rescue therapy with TACROLIMUS and discharged with a mean serum creatinine level of 1.4 mg/dL (range, 1.1 mg/dL to 1.7 mg/dL). Allograft nephrectomy was done in 8 patients (23.5%) because of no response to treatment of rejection, the pathology reports of which consisted of acute vascular rejection in 5 patients and extensive necrosis in 3.Conclusion: TACROLIMUS therapy is able to salvage kidney allografts with acute refractory rejection. We recommend that TACROLIMUS be used as an alternative to the conventional drugs used for antirejection therapy. However, severe infectious complications as a result of overt immunosuppression must be considered.

Cites

No record.

References

No record.

Cite

APA: Copy

NADERI, GH.H., MEHRABAN, DARAB, GANJI, M.R., YAHYAZADEH, S.R., & LATIF, A.H.. (2009). TACROLIMUS RESCUE THERAPY FOR CORTICOSTEROID-RESISTANT AND POLYCLONAL ANTIBODY-RESISTANT KIDNEY ALLOGRAFT REJECTIONS. UROLOGY JOURNAL, 6(1), 31-34. SID. https://sid.ir/paper/270864/en

Vancouver: Copy

NADERI GH.H., MEHRABAN DARAB, GANJI M.R., YAHYAZADEH S.R., LATIF A.H.. TACROLIMUS RESCUE THERAPY FOR CORTICOSTEROID-RESISTANT AND POLYCLONAL ANTIBODY-RESISTANT KIDNEY ALLOGRAFT REJECTIONS. UROLOGY JOURNAL[Internet]. 2009;6(1):31-34. Available from: https://sid.ir/paper/270864/en

IEEE: Copy

GH.H. NADERI, DARAB MEHRABAN, M.R. GANJI, S.R. YAHYAZADEH, and A.H. LATIF, “TACROLIMUS RESCUE THERAPY FOR CORTICOSTEROID-RESISTANT AND POLYCLONAL ANTIBODY-RESISTANT KIDNEY ALLOGRAFT REJECTIONS,” UROLOGY JOURNAL, vol. 6, no. 1, pp. 31–34, 2009, [Online]. Available: https://sid.ir/paper/270864/en

Related Journal Papers

No record.

Related Seminar Papers

No record.

Related Plans

No record.

Recommended Workshops